Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2011-03-29
2011-03-29
Cordero Garcia, Marcela M (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
Reexamination Certificate
active
07915240
ABSTRACT:
Method of using immunomodulatory compounds for treating diseases related to an overproduction of inflammatory cytokines, including diseases selected from asthma, atopic dermatitis, allergic rhinitis, prostatitis, inflammatory bowel disease, diabetes, and rhumatoid arthritis, the compounds being of general formula (I):wherein:m and n, independently from each other, are an integer ranging from 1 to 4,X and Y represent —COOH, —O—P(O)(OH)2, —O—SO2(OH), —NH2, —OH, —CONH(CH2)n1—NH2, —CO—NH—CH(COOH)—(CH2)n1—COOH, —CO—NH—CH(COOH)—(CH2)n1—NH2, —O—CO—(CH2)n1—NH2, —O—CO—(CH2)n1—CHOH—CH2OH, —O—CO—(CH2)n1—OH, —O—CO—(CH2)n1—COOH, —O—CO—(CH2)n1—CHO, —O—CO—(CH2)n1—NH—CO—(CH2)n2—COOH,R1and R2each designate an acyl group derived from a saturated or unsaturated, straight- or branched-chain carboxylic acid having from 2 to 18 carbon atoms, which is unsubstituted or bears one to three substituents selected among hydroxyl, dihydroxyphosphoryloxy, alkyl of 2 to 18 carbon atoms, alkoxy of 2 to 18 carbon atoms, acyloxy of 2 to 18 carbon atoms in the acyl moiety, amino, acylamino.
REFERENCES:
patent: 6297257 (2001-10-01), Napoletano et al.
patent: 6831069 (2004-12-01), Tam et al.
patent: 7157092 (2007-01-01), Bauer et al.
patent: 7799762 (2010-09-01), Bauer et al.
patent: 2003/0203852 (2003-10-01), Bauer et al.
patent: 2005/0192232 (2005-09-01), Bauer et al.
patent: 2006/0148678 (2006-07-01), Bauer et al.
patent: 20220947 (2002-02-01), None
patent: 1081132 (1999-05-01), None
patent: 1 081 132 (2004-03-01), None
patent: 2051728 (2009-04-01), None
patent: WO00/00462 (2000-12-01), None
patent: WO 01/46127 (2001-06-01), None
patent: WO 01/57233 (2001-08-01), None
patent: WO 01/57233 (2001-08-01), None
Frieri. Nitric Oxide in Allergic Rhinitis and Asthma. Allergy and Asthma Proceedings. 1998, No. 19, pp. 349-351.
Chan et al. Nitric oxide and vascular responses in Type I diabetes. Diabetologia. 2000. vol. 43, pp. 137-147.
Taniuchi et al. Increased serum nitrate levels in infants with atopic dermatitis. Allergy, 2001. vol. 56, pp. 693-695.
EPO machine language translation from German to English for DE 20220947, Feb. 2002, 29 pages.
Byl et al., “OM197-MP-AC induces the maturation of human dendritic cells and promotes a primary T cell responce,” Int. Immunopharm., vol. 3, pp. 417-425 (2003).
European Communication Pursuant to Article 94(3) EPC, Apr. 12, 2010, for OM Pharma, European Application No. 07733936.4, filed Mar. 9, 2007.
Bauer Jacques
Chiavaroli Carlo
Moutel Stéphane
Cordero Garcia Marcela M
Law Offices of Albert Wai-Kit Chen, PLLC
OM Pharma
LandOfFree
Immunomodulatory compounds and treatment of diseases related... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunomodulatory compounds and treatment of diseases related..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunomodulatory compounds and treatment of diseases related... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2746143